SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 36 filers reported holding SQZ BIOTECHNOLOGIES CO in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $31,760 | – | 42,919 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 1,330,889 | $984,857 | 0.08% |
| Artal Group S.A. | 1,606,309 | $1,189 | 0.07% |
| Sandy Cove Advisors, LLC | 51,707 | $38,263 | 0.03% |
| MAVERICK CAPITAL LTD | 1,068,155 | $790,435 | 0.02% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,517,173 | $1,862,708 | 0.01% |
| Temasek Holdings (Private) Ltd | 2,758,169 | $2,041,045 | 0.01% |
| RBF Capital, LLC | 127,930 | $94,000 | 0.01% |
| ADVISORS MANAGEMENT GROUP INC /ADV | 14,000 | $10 | 0.00% |
| Ergoteles LLC | 64,215 | $47,519 | 0.00% |
| Baldrige Asset Management LLC | 5,000 | $4 | 0.00% |